190 related articles for article (PubMed ID: 7525612)
1. Ornithine decarboxylase gene expression is aberrantly regulated via the cAMP signal transduction pathway in malignant H-ras transformed cell lines.
Hurta RA; Wright JA
J Cell Physiol; 1994 Nov; 161(2):383-91. PubMed ID: 7525612
[TBL] [Abstract][Full Text] [Related]
2. Alterations in the cyclic AMP signal transduction pathway regulating ribonucleotide reductase gene expression in malignant H-ras transformed cell lines.
Hurta RA; Wright JA
J Cell Physiol; 1994 Jan; 158(1):187-97. PubMed ID: 7505277
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta 1 selectively regulates ornithine decarboxylase gene expression in malignant H-ras transformed fibrosarcoma cell lines.
Hurta RA; Greenberg AH; Wright JA
J Cell Physiol; 1993 Aug; 156(2):272-9. PubMed ID: 8344985
[TBL] [Abstract][Full Text] [Related]
4. Tumour promoter mediated altered expression and regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase in H-ras-transformed fibrosarcoma cell lines.
Voskas D; Mader R; Lee J; Hurta RA
Biochem Cell Biol; 2001; 79(1):69-81. PubMed ID: 11235918
[TBL] [Abstract][Full Text] [Related]
5. Transformation by H-ras can result in aberrant regulation of ornithine decarboxylase gene expression by transforming growth factor-beta(1).
Hurta RA; Lee J; Voskas D
J Cell Biochem; 2001; 81(1):39-55. PubMed ID: 11180396
[TBL] [Abstract][Full Text] [Related]
6. Rapid expression of ornithine decarboxylase mRNA in a macrophage-like cell line: cAMP repression of the requirement for prior protein synthesis.
Shurtleff SA; McElwain CM; Taffet SM
J Cell Physiol; 1988 Mar; 134(3):453-9. PubMed ID: 2832424
[TBL] [Abstract][Full Text] [Related]
7. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
Shantz LM; Pegg AE
Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886
[TBL] [Abstract][Full Text] [Related]
8. S-Adenosylmethionine decarboxylase gene expression is regulated by the cAMP signal transduction pathway in H-ras transformed fibrosarcoma cells capable of malignant progression.
Hurta RA
J Cell Biochem Suppl; 2001; Suppl 36():209-21. PubMed ID: 11455586
[TBL] [Abstract][Full Text] [Related]
9. Expression of hepatocyte growth factor is up-regulated through activation of a cAMP-mediated pathway.
Matsunaga T; Gohda E; Takebe T; Wu YL; Iwao M; Kataoka H; Yamamoto I
Exp Cell Res; 1994 Feb; 210(2):326-35. PubMed ID: 7507855
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor activity of antizyme which targets the ornithine decarboxylase (ODC) required for cell growth and transformation.
Iwata S; Sato Y; Asada M; Takagi M; Tsujimoto A; Inaba T; Yamada T; Sakamoto S; Yata J; Shimogori T; Igarashi K; Mizutani S
Oncogene; 1999 Jan; 18(1):165-72. PubMed ID: 9926931
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of secretogranin II and chromogranin B by cyclic AMP in a rat pheochromocytoma cell line.
Thompson ME; Valentine DL; Strada SJ; Wagner JA; Scammell JG
Mol Pharmacol; 1994 Nov; 46(5):880-9. PubMed ID: 7969075
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta1 selectively regulates ferritin gene expression in malignant H-ras-transformed fibrosarcoma cell lines.
Lo J; Hurta RA
Biochem Cell Biol; 2000; 78(4):527-35. PubMed ID: 11012093
[TBL] [Abstract][Full Text] [Related]
13. [Specific induction by phorbol ester of the gene transcription and of the activity of ornithine decarboxylase in two control and transformed epithelial cell lines. Modulator effect of anti-inflammatory agents].
Nguyen-Ba G; Robert S; Lasne C; Ventura L; Chouroulinkov I; van Kreijl CF; van Steeg H; Truhaut R
C R Acad Sci III; 1992; 314(11):485-92. PubMed ID: 1521167
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of oncogenic N-ras-induced neurite outgrowth and ornithine decarboxylase activity by phorbol dibutyrate and protein kinase inhibitor H-8.
Trotta RJ; Thomson TM; Lacal JC; Pellicer A; Burstein DE
J Cell Physiol; 1990 Apr; 143(1):68-78. PubMed ID: 2180965
[TBL] [Abstract][Full Text] [Related]
15. Cyclic AMP mediated GSTP1 gene activation in tumor cells involves the interaction of activated CREB-1 with the GSTP1 CRE: a novel mechanism of cellular GSTP1 gene regulation.
Lo HW; Ali-Osman F
J Cell Biochem; 2002; 87(1):103-16. PubMed ID: 12210727
[TBL] [Abstract][Full Text] [Related]
16. Regulation of ornithine decarboxylase gene expression in mouse epidermis and epidermal tumors during two-stage tumorigenesis.
Gilmour SK; Verma AK; Madara T; O'Brien TG
Cancer Res; 1987 Mar; 47(5):1221-5. PubMed ID: 3815331
[TBL] [Abstract][Full Text] [Related]
17. Modulation of cellular interactions between C3H/10T1/2 cells and their transformed counterparts by phosphodiesterase inhibitors.
Bertram JS
Cancer Res; 1979 Sep; 39(9):3502-8. PubMed ID: 89899
[TBL] [Abstract][Full Text] [Related]
18. Alteration of phosphoinositide metabolism by attenuation of cAMP resulting from expression of the H-ras oncogene.
Murphy SK; Lindberg JB; Prussack DA
Biochem Biophys Res Commun; 1994 Dec; 205(2):1121-9. PubMed ID: 7802640
[TBL] [Abstract][Full Text] [Related]
19. Regulation of C/EBPbeta mRNA expression and C/EBPbeta promoter activity by protein kinases A and C in a myelomonocytic cell line (HD11).
Goethe R; Basler T; Phi-van L
Inflamm Res; 2007 Jul; 56(7):274-81. PubMed ID: 17659432
[TBL] [Abstract][Full Text] [Related]
20. Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation.
Jansen AP; Colburn NH; Verma AK
Oncogene; 1999 Oct; 18(42):5806-13. PubMed ID: 10523861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
